Name | (ac-cys-oh)2 |
---|---|
Synonyms |
N,N`-Diacetyl-L-cystine
N,N'-Diacetyl-L-cystine N,N'-diacetyl-cystine N-acetyl-L-cystine ACETYL-L-CYSTINE DiNAC L-Cystine, N,N'-diacetyl- Cystine, N,N'-diacetyl-, L- diacetylcysteine L-Cystine,N,N'-diacetyl N,N''-Diacetyl-L-cysteine N-ACETYL CYSTINE |
Description | N,N'-diacetyl-L-cystine (DiNAC) is the disulphide dimer of N-acetylcysteine with immunomodulating properties. N,N'-diacetyl-L-cystine is a potent, orally active modulator of contact sensitivity/delayed type hypersensitivity reactions in rodents. N,N'-diacetyl-L-cystine also has antiatherosclerotic effects in Watanabe-heritable hyperlipidemic rabbit (WHHL) rabbits[1][2]. |
---|---|
Related Catalog | |
Target |
Immunomodulator[1] |
In Vivo | N,N'-Diacetyl-L-cystine (DiNAC; 0-973.11 μg/kg; oral administration; daily; for 12 weeks; WHHL rabbits) treatment reduces by 50% thoracic aorta atherosclerosis, without affecting plasma lipid levels[1]. Animal Model: Male heritable hyperlipidemic rabbit (WHHL) rabbits (10-22 weeks)[1] Dosage: 0 μg/kg, 9.73 μg/kg, or 973.11 μg/kg Administration: Oral administration; daily; for 12 weeks Result: Reduced by 50% thoracic aorta atherosclerosis, without affecting plasma lipid levels. |
References |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 715.5±60.0 °C at 760 mmHg |
Melting Point | 55-72ºC |
Molecular Formula | C10H16N2O6S2 |
Molecular Weight | 324.374 |
Flash Point | 386.5±32.9 °C |
Exact Mass | 324.044983 |
PSA | 183.40000 |
LogP | 0.46 |
Vapour Pressure | 0.0±5.0 mmHg at 25°C |
Index of Refraction | 1.583 |
Storage condition | -15°C |
Stability | Moisture Sensitive |
HS Code | 29225090 |
---|
~98% 5545-17-5 |
Literature: Oba, Makoto; Tanaka, Kazuhito; Nishiyama, Kozaburo; Ando, Wataru Journal of Organic Chemistry, 2011 , vol. 76, # 10 p. 4173 - 4177 |
~0% 5545-17-5 |
Literature: Stamler, Jonathan S.; Loscalzo, Joseph Analytical Chemistry, 1992 , vol. 64, # 7 p. 779 - 785 |
~% 5545-17-5 |
Literature: Journal of Biological Chemistry, , vol. 94, p. 244 Archives of Biochemistry, , vol. 18, p. 379 |
~22% 5545-17-5 |
Literature: Watzig; Dette; Aigner; Wilschowitz Pharmazie, 1994 , vol. 49, # 4 p. 249 - 252 |
~% 5545-17-5 |
Literature: Inorganic chemistry, , vol. 39, # 8 p. 1728 - 1734 |
~% 5545-17-5 |
Literature: Biochemical Journal, , vol. 25, p. 619 Rikagaku Kenkyusho Iho, , vol. 8, p. 647,650 Chem. Zentralbl., , vol. 100, # II p. 2770 |
~% 5545-17-5 |
Literature: Biochemical Journal, , vol. 25, p. 619 Rikagaku Kenkyusho Iho, , vol. 8, p. 647,650 Chem. Zentralbl., , vol. 100, # II p. 2770 |
~% 5545-17-5 |
Literature: Photochemistry and Photobiology, , vol. 71, # 3 p. 273 - 280 |
~% 5545-17-5 |
Literature: Canadian Journal of Chemistry, , vol. 76, # 6 p. 789 - 794 |
Precursor 8 | |
---|---|
DownStream 3 | |